Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1231457 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $3.05Day +7.77%Mkt cap $127M1Y −13.6%Off 52W high −64.3%Vol (1Y) 80.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 877 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest6.9% of sh out |
| Days to cover17.9d |
| 13F net flow (QoQ)+1.19% |
| Top-10 13F concentration78.8% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$8,000 |
| Earnings (TTM)-$33.6M |
| ROE−170.0% |
| Net margin−401812.5% |
| Sales growth 3Y−91.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−30.0% |
| 1Y−13.6% |
| 3Y−85.5% |
| Since incept. (ann.)−18.1% |
Total return through 2026-07-30 · series begins 2023-01-26. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)80.9% |
| Ann. volatility (3Y)99.7% |
| Sharpe (1Y)0.24 |
| Sharpe (3Y)−0.14 |
| Max drawdown (1Y)−72.1% |
| Max drawdown (3Y)−94.6% |
| Beta (3Y vs SPY)1.51 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| WOODWARD DIVERSIFIED CAPITAL, LLC | 2.1M | $6M | 4.73% | +9.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $4M | 3.78% | new |
| Bleichroeder LP | 1.4M | $3M | 3.08% | +93.4% |
| GEODE CAPITAL MANAGEMENT, LLC | 453,761 | $1M | 1.01% | +19.0% |
| BlackRock, Inc. | 405,872 | $982,210 | 0.91% | +5.3% |
| BANK OF AMERICA CORP /DE/ | 323,865 | $783,753 | 0.72% | −3.6% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 280,904 | $679,788 | 0.63% | −7.4% |
| VANGUARD FIDUCIARY TRUST CO | 251,610 | $608,896 | 0.56% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.20 | — | — | — |
| 2025-09-30 | 2025-11-05 | −$0.21 | — | — | — |
| 2025-06-30 | 2025-08-07 | −$0.20 | — | — | — |
| 2025-03-31 | 2025-05-06 | −$0.21 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
Operating And Reportable Segments 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
